Iwase, Toshiaki
Sridhar, Nithya
Kai, Megumi
Dong, Wenli
Shen, Yu
Krishnamurthy, Savitri
Lucci, Anthony
Le-Petross, H. T. Carisa
Nasrazadani, Azadeh
Saleem, Sadia
Layman, Rachel M.
Valero, Vincente
Tripathy, Debasish
Woodward, Wendy A.
Cheng, Yee Chung
Nakhlis, Faina
Bellon, Jenifer R.
Lynce, Filipa
Ueno, Naoto T.
Funding for this research was provided by:
National Institutes of Health (P30CA016672, P30CA016672, 1R01CA205043-01A1)
Article History
Received: 10 May 2025
Accepted: 22 July 2025
First Online: 2 August 2025
Declarations
:
: The authors declare no competing interests.
: The institutional review boards at The University of Texas MD Anderson Cancer Center and Dana-Farber Cancer Institute approved this study.
: Patients’ Consent for study participation was waived owing to the anonymized retrospective nature of the study design.
: The MD Anderson IRB waived the consent for publishing due to the nature of the anonymized retrospective study design.